Intrathecal chloroprocaine-not yet "safe" by US FDA parameters

International Anesthesiology Clinics

Volumn 50, Issue 1, 2012, Pages 93-100

  Pollock, Julia E ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROPROCAINE; LIDOCAINE;

ARTICLE; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HISTORY OF MEDICINE; HUMAN; NERVOUS SYSTEM INJURY; NEUROTOXICITY; NONHUMAN; PARAMETERS; POSTDURAL PUNCTURE HEADACHE; PRIORITY JOURNAL; SPINAL ANESTHESIA; TREATMENT DURATION;

ANESTHESIA, SPINAL; ANESTHETICS, LOCAL; DRUG APPROVAL; HUMANS; INJECTIONS, SPINAL; NERVE BLOCK; PROCAINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84855888991     PISSN: 00205907     EISSN: 15371913     Source Type: Journal    
DOI: 10.1097/AIA.0b013e31821bbb35     Document Type: Article

References (43)

1. Rigler M, Drasner K, Krejcie T, et al. Cauda equina syndrome after continuous spinal anesthesia. Anesth Analg. 1991;72:275-281
2. Schneider M, Ettlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg. 1993;76: 1154-1157 (Pubitemid 23139480)
3. Pollock JE, Neal JM, Stephenson CA, et al. Prospective study of the incidence of transient radicular irritation in patients undergoing spinal anesthesia. Anesthesiology. 1996;84:1361-1367 (Pubitemid 26192044)
4. Hampl KF, Schneider MC, Pargger H, et al. A similar incidence of transient neurologic symptoms after spinal anesthesia with 2% and 5% lidocaine. Anesth Analg. 1996;83:1051-1054 (Pubitemid 26365421)
5. Tarkkila P, Huhtala J, Tuominen M. Transient radicular irritation after spinal anaesthesia with hyperbaric 5% lignocaine. Br J Anaesth. 1995;74:328-329
6. Pollock JE. Transient neurologic symptoms; Etiology, risk factors and management. Reg Anesth Pain Med. 2002;27:581-586 (Pubitemid 35387146)
7. Foldes FF, McNall PG. 2-Chloroprocaine: a new local anesthetic agent. Anesthesiology. 1952;13:287-296
8. Kim YI, Massa NM, Marx GF. Massive spinal block with hemicranial palsy after a "test dose" for extradural anesthesia. Anesthesiology. 1975;43:370-372
9. Woerth SC, Bullard RJ, Alpert CC. Total spinal anesthesia, a late complication of epidural anesthesia. Anesthesiology. 1977;47:380-381 (Pubitemid 8163035)
10. Allen PR, Johnson RW. Subarachnoid injection during extradural analgesia for labour using 2-Chloroprocaine. Anaesthesia. 1979;34:874-876 (Pubitemid 10161592)
11. Ravindran RS, Bond VK, Tasch MD, et al. Prolonged neural blockade following regional analgesia with 2-chloroprocaine. Anesth Analg. 1980;59:447-451 (Pubitemid 10120272)
12. Reisner LS, Hochman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection. Anesth Analg. 1980;59: 452-454 (Pubitemid 10120273)
13. Moore DC, Spierdijk J, VanKleef J, et al. 2-chloroprocaine neurotoxicity: four additional cases. Anesth Analg. 1982;61:155-159 (Pubitemid 12184642)
14. Pizzolato P, Renegar OJ. Histopathologic effects of long exposure to local anesthetics on peripheral nerves. Anesth Analg. 1959;38;138-141
15. Feldman HS, Covino BG. A chronic model for investigation of experimental spinal anesthesia in the dog. Anesthesiology. 1981;54:148-152 (Pubitemid 11170344)
16. Barsa J, Batra MS, Fink BR, et al. A comparative in vivo study of local neurotoxicity of lidocaine, bupivacaine, 2-chloroprocaine and a mixture of 2-chloroprocaine and bupivacaine. Anesth Analg. 1982;61:961-967 (Pubitemid 13224419)
17. Ravindran RS, Turner MS, Muller J. Neurologic effects of subarachnoid administration of 2-chloroprocaine-CE, bupivacaine and low pH normal saline in dogs. Anesth Analg. 1982;61:279-283 (Pubitemid 12136113)
18. Rosen MA, Baysinger CL, Shnider SM, et al. Evaluation of neurotoxicity after subarachnoid injection of large volumes of local anesthetic solutions. Anesth Analg. 1983;62:802-808 (Pubitemid 13044065)
19. Wang BC, Hillman DE, Spielholz NI, et al. Chronic neurological deficits and Nesacaine-CE-an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite?. Anesth Analg. 1984;63:445-447 (Pubitemid 14172618)
20. Gissen AJ, Datta S, Lambert D. The chloroprocaine controversy I: a hypothesis to explain the neural complications of chloroprocaine epidural. Reg Anesth. 1984;9: 124-134 (Pubitemid 14049203)
21. Gissen AJ, Datta S, Lambert D. The chloroprocaine controversy II: is chloroprocaine neurotoxic? Reg Anesth. 1984;9:135-145
22. Ready BL, Plumer MH, Haschke RH, et al. Neurotoxicity of intrathecal local anesthetics in rabbits. Anesthesiology. 1985;63:364-370 (Pubitemid 16236051)
23. Seravalli EP, Lear E, Cottrell JE. Cell membrane fusion by chloroprocaine. Anesth Analg. 1984;63:983-990
24. Kalichman MW, Powell HC, Reisner LS, et al. The role of 2-chloroprocaine and sodium bisulfite in rat sciatic nerve edema. J Neuropathol Exp Neurol. 1986;45: 566-575 (Pubitemid 16054025)
25. Ford DJ, Raj PP. Peripheral neurotoxicity of 2-chloroprocaine and bisulfite in the cat. Anesth Analg. 1987;66:719-722 (Pubitemid 17105067)
26. Hersh EV, Condouris GA, Havelin D. Actions of intrathecal chloroprocaine and sodium bisulfite on rat spinal reflex function utilizing a noninvasive technique. Anesthesiology. 1990;72:1077-1082 (Pubitemid 20204667)
27. Taniguchi M, Bollen AW, Drasner K. Sodium bisulfite-scapegoat for chloroprocaine neurotoxicity. Anesthesiology. 2004;100:85-91
28. Winnie AP, Nader AM. Santayanas prophecy fulfilled. Reg Anesth. 2001;26:558-564
29. Konig W, Ruzicic D. Absence of transient radicular irritation after 5000 spinal anaesthetics with prilocaine. Anaesthesia. 1997;52:182-183 (Pubitemid 27101629)
30. Hampl KF, Heinzmann-Wiedmer S, Luginbuehol I. Transient neurologic symptoms: a lower incidence with prilocaine and bupivacaine than lidocaine. Anesthesiology. 1998; 88:629-633
31. Kouri ME, Kopacz DJ. Spinal 2-Chloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg. 2004;98:75-80 (Pubitemid 38029848)
32. Vath JS, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added fentanyl. Anesth Analg. 2004;98:89-94 (Pubitemid 38029851)
33. Smith KN, Kopacz DJ, McDonald SB. Spinal 2-chloroprocaine: a dose-ranging study and the effect of added epinephrine. Anesth Analg. 2004;98:81-88 (Pubitemid 38029849)
34. Warren DT, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added dextrose. Anesth Analg. 2004;98:95-101 (Pubitemid 38029852)
35. Kopacz DJ. Spinal 2-chloroprocaine: minimum effective dose. Reg Anesth and Pain Med. 2005;30:36-42 (Pubitemid 40187269)
36. Davis BR, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added clonidine. Anesth Analg. 2005;100:559-565 (Pubitemid 40170561)
37. Yoos JR, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with small-dose bupivacaine in volunteers. Anesth Analg. 2005;100:566-572 (Pubitemid 40170562)
38. Gonter AF, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with procaine in volunteers. Anesth Analg. 2005;100:573-579 (Pubitemid 40170563)
39. Yoos JR, Kopacz DJ. Spinal 2-chloroprocaine for surgery: an initial 10-month experience. Anesth Analg. 2005;100:553-558 (Pubitemid 40170560)
40. Casati A, Fanelli G, Danelli G, et al. Spinal anesthesia with lidocaine or preservative free 2-chlorprocaine for outpatient knee arthroscopy: a prospective, randomized, double blind comparison. Anesth Analg. 2007;104:959-964 (Pubitemid 46548329)
41. Casati A, Danelli G, Berti M, et al. Intrathecal 2-chloroprocaine for lower limb outpatient surgery: a prospective, randomized, double-blind, clinical evaluation. Anesth Analg. 2006;103:234-238 (Pubitemid 44036065)
42. Sell A, Tein T, Pitkanen M. Spinal 2-chloroprocaine: effective dose for ambulatory surgery. Acta Anaesthesiol Scand. 2008;52:695-699 (Pubitemid 351549581)
43. Hejtmanek MR, Pollock JE. Chloroprocaine for spinal anesthesia: a retrospective analysis. Acta Anaesthesiol Scand. 2011;55:267-272